Full Name
Prof. Matt Inada-Kim
Job Title
Consultant Acute Physician, Hampshire Hospitals NHS & University of Southampton, National Clinical Director, Infection Management and Antimicrobial Resistance, NHS England, UK Health Security Agency
Speaker Bio
Matt is a Consultant acute physician at Hampshire Hospitals, visiting professor at the University of Southampton.
He is currently the National Clinical Director for Infection management, Antimicrobial Resistance and previously National Clinical Lead Deterioration, National Specialty Advisor Sepsis, leads for COVID oximetry@home, Acute respiratory infection (ARI) hubs, NHS@home and for the Deterioration and Sepsis CQUINs. He chairs the National Deterioration forum that has a membership of over 1,000 NHS clinicians and managerial leads.
He is also an academic and led the research in COVID patients that proved that oxygen saturations at home predicted outcomes, purchase of 1.2 million oximeters and clinically led the COVID oximetry at home project in all settings. He shared this home monitoring / safe admission avoidance strategy globally with the World Health Organisation (WHO) and across 18 countries during the pandemic leading to some countries purchasing oximeters for every household; now demonstrated to reduce mortality rates due to COVID by 50% at 30 days/1 year.
Following this, he led the development/implementation of 400 ARI hubs, that saw over 700,000 patients over 4 months.
He is a recognised international expert in sepsis- clinical pathways, data/measurement and improvement, deterioration, integrated and virtual care and multiple webinars with the WHO, IHI and all national UK societies/colleges, winning a hatrick of HSJ awards in these domains.
He is currently the National Clinical Director for Infection management, Antimicrobial Resistance and previously National Clinical Lead Deterioration, National Specialty Advisor Sepsis, leads for COVID oximetry@home, Acute respiratory infection (ARI) hubs, NHS@home and for the Deterioration and Sepsis CQUINs. He chairs the National Deterioration forum that has a membership of over 1,000 NHS clinicians and managerial leads.
He is also an academic and led the research in COVID patients that proved that oxygen saturations at home predicted outcomes, purchase of 1.2 million oximeters and clinically led the COVID oximetry at home project in all settings. He shared this home monitoring / safe admission avoidance strategy globally with the World Health Organisation (WHO) and across 18 countries during the pandemic leading to some countries purchasing oximeters for every household; now demonstrated to reduce mortality rates due to COVID by 50% at 30 days/1 year.
Following this, he led the development/implementation of 400 ARI hubs, that saw over 700,000 patients over 4 months.
He is a recognised international expert in sepsis- clinical pathways, data/measurement and improvement, deterioration, integrated and virtual care and multiple webinars with the WHO, IHI and all national UK societies/colleges, winning a hatrick of HSJ awards in these domains.
